Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: Relationship with disease activity in rheumatoid arthritis

Journal of Rheumatology

Volumn 25, Issue 12, 1998, Pages 2440-2444

  Chen, Jin Ran ^b   Takahashi, Masaaki ^a   Suzuki, Motohiro ^b   Kushida, Kazuhiro ^b   Miyamoto, Shigehito ^b   Inoue, Tetsuo ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Advanced glycation endproduct; Crosslinks; Oxygen radicals

Indexed keywords

C REACTIVE PROTEIN; PENTOSIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; OXIDATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN GLYCOSYLATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ARGININE; ARTHRITIS, RHEUMATOID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA INTERPRETATION, STATISTICAL; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; LYSINE; MIDDLE AGED; OSTEOARTHRITIS; PREDNISOLONE; SEVERITY OF ILLNESS INDEX; STEROIDS; SYNOVIAL FLUID;

EID: 0005649096     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Halliwell B, Hoult JR, Blake DR. Oxidants, inflammation, and antiinflammatory drugs. FASEB J 1988;2:2867-73.
2. Santos L, Tipping PG. Attenuation of adjuvant arthritis in rats by treatment with oxygen radical scavengers. Immunol Cell Biol 1994;72:406-14.
3. Schenck P, Schneider S, Miehlke R, Prehm P. Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis. J Rheumatol 1995;22:400-5.
4. Merry P, Winyard PG, Morris CJ, Grootveld M, Blake DR. Oxygen free radicals, inflammation, and synovitis: the current status. Ann Rheum Dis 1989;48:864-70.
5. Halliwell B. Oxygen radicals and human disease. Ann Intern Med 1987;107:526-45.
6. Halliwell B, Gutteridgeand JMC. The importance of free radicals and catalytic metal ions in human disease. Mol Aspect Med 1985;8:89-193.
7. Shingu M, Isayama T, Yasutake C, et al. Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation. Inflammation 1994;18:613-23.
8. Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 1994;53:51-3.
9. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 1989;264: 21597-602.
10. Sell DR, Monnier VM. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 1990;85:380-4.
11. Odetti P, Fogarty J, Sell DR, Monnier VM. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992;41:153-9.
12. Takahashi M, Ohishi T, Aoshima H, et al. The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia 1993;36:664-7.
13. Uchiyama A, Ohishi T, Takahashi M, et al. Fluorophores from aging human articular cartilage. J Biochem 1991;110:714-8.
14. Monnier VM, Sell DR, Nagaraj R, et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 1992;41 Suppl 2:36-41.
15. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993;91:2463-9.
16. Dyer DG, Blackledge JA, Thorpe SR, Bynes JW. Formation of pentosidine during nonenzymatic browning of proteins by glucose. J Biol Chem 1991;266:11654-60.
17. Grandhee SK, Monnier VM. Mechanism of formation of the Maillard protein cross-link pentosidine. J Biol Chem 1991;266:11649-53.
18. Fu MX, Knecht KJ, Thorpe SR, Baynes JW. Role of oxygen in cross-linking and chemical modification of collagen by glucose. Diabetes 1992;41 Suppl 2:42-8.
19. Takahashi M, Kushida K, Ohishi T, et al. Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum 1994;37:724-8.
20. Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue T. Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. Br J Rheumatol 1997;36:637-42.
21. Lansbury J. Numerical method of evaluating the status of rheumatoid arthritis. Ann Rheum Dis 1957;16:101-7.
22. Lansbury J. Methods for evaluating rheumatoid arthritis. In: Hollander JL. editor. Arthritis and allied conditions. 7th edition. Philadelphia: Lea and Febiger: 1966;269-91.
23. Takahashi M, Hoshino H, Kushida K, Kawana K, Inoue T. Direct quantification of pentosidine in urine and serum by HPLC with column switching. Clin Chem 1996;42:1439-44.
24. Takahashi M, Hoshino H, Kushida K, Inoue T. Direct measurement of crosslinks, pyridinoline, deoxypyridinoline, and pentosidine, in the hydrolysate of tissues using high-performance liquid chromatography. Anal Biochem 1995;232:158-62.
25. Lunec J, Halloran SP, White AG, Dormandy TL. Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 1981;8:233-45.
26. Takahashi M, Kushida K, Kawana K, et al. Quantitation of the cross-link, pentosidine in serum from normal and uremic subjects. Clin Chem 1993;39:2162-5.